The Effect of Hormonal Supplements on Metabolic Syndrome

The implications of hormonal therapy in the context of metabolic syndrome (MetS) present a complex landscape that warrants scrutiny. This discourse delves into the current understanding of hormonal interventions, emphasizing the necessity for robust experimental preclinical studies across diverse age demographics. It advocates for the execution of further randomized controlled multicentric trials to ascertain the potential of hormonal therapy in either preventing or mitigating the manifestations of MetS in both women and men, particularly as they traverse various menopausal stages. If validated, the efficacy of hormonal therapy could serve as a cornerstone for innovative strategies aimed at combating MetS in the foreseeable future. Moreover, it is imperative to conduct randomized controlled multicentric trials that build upon existing observational research, including the insights provided by this analysis. The exploration of hormonal profiles post-supplementation remains a critical avenue for future inquiry, poised to illuminate the therapeutic advantages of hormonal supplementation for individuals afflicted with MetS, whether utilized in isolation or a synergistic framework.